Clinical Trials Logo

Clinical Trial Summary

Data from the National Cancer Institute (Inca) reveal that breast cancer is the most common type of cancer among women worldwide. In Brazil, it is second only to non-melanoma skin cancer. Breast cancer is a feared disease in the female universe because it is considered one of the major causes of death due to neoplasia among women. It brings also the stigma of suffering, mutilation, loss of female identity and loss of body contour. Among other issues, problems with body self-image may have an impact on sexuality and fertility, and also, the incapacity to breastfeed. Breast reconstruction can restore the patient's shape and physical integrity, among other benefits. The research justifies itself because information about the satisfaction of breast reconstruction can be achieved. It is also known that women having breast reconstruction after a mastectomy due to cancer have a favorable evolution. This study will analyze body contour satisfaction of women undergoing mastectomy and breast reconstruction as part of their breast cancer treatment. The Breast Q questionnaire will be used to measure patients satisfaction.


Clinical Trial Description

This is a prospective, quasi-experimental study. The subject sample will be composed of women submitted to mastectomy due to breast cancer and to breast reconstruction as part of their treatment. They will be evaluated twice. One when they receive the cancer diagnosis and the other six months after de reconstruction surgery. On both occasions, they will answer the Brest Q questionnaire. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03777852
Study type Interventional
Source University of Sao Paulo
Contact Helio HA Carrara, MD, PhD
Phone 551636021000
Email carrara@fmrp.usp.br
Status Not yet recruiting
Phase N/A
Start date July 1, 2019
Completion date February 28, 2022

See also
  Status Clinical Trial Phase
Completed NCT01372917 - Evaluating AlloMax in Immediate Expander-Based Breast Reconstruction Study N/A